1. Home
  2. AIRS vs PROF Comparison

AIRS vs PROF Comparison

Compare AIRS & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIRS

AirSculpt Technologies Inc.

HOLD

Current Price

$2.76

Market Cap

328.7M

Sector

Health Care

ML Signal

HOLD

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$7.35

Market Cap

263.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRS
PROF
Founded
2012
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Nursing Services
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
328.7M
263.8M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
AIRS
PROF
Price
$2.76
$7.35
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
385.4K
115.0K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.89
EPS
N/A
N/A
Revenue
$151,818,000.00
$16,098,000.00
Revenue This Year
$5.19
$92.40
Revenue Next Year
$5.32
$64.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
50.73
52 Week Low
$1.51
$3.92
52 Week High
$12.00
$8.95

Technical Indicators

Market Signals
Indicator
AIRS
PROF
Relative Strength Index (RSI) 26.09 50.16
Support Level $2.40 $6.17
Resistance Level $3.36 $7.93
Average True Range (ATR) 0.32 0.52
MACD -0.10 0.01
Stochastic Oscillator 9.44 38.40

Price Performance

Historical Comparison
AIRS
PROF

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

Share on Social Networks: